Key Dates

Related Announcements

• September 9, 2022 - NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed). See NOFO PAR-22-225.

Issued by

National Institute of Allergy and Infectious Diseases (NIAID)

Purpose

This Notice extends PAR-22-225 "NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)" for one Council round. PAR-22-225 will now expire May 8, 2026.

The following sections of the NOFO have been changed:

Currently reads:

Part 1. Overview Information

Key Dates

Application Due Date(s)

January 11, 2023; June 8, 2023; January 11, 2024; June 11, 2024; January 10, 2025; June 11, 2025

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

AIDS Application Due Date(s)

May 7, 2023; September 7, 2023; May 7, 2024; September 7, 2024; May 7, 2025; September 7, 2025

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

Non-AIDS Applications: June 2023; October 2023; June 2024; October 2024; June 2025; October 2025

AIDS Applications: June 2023; October 2023; June 2024; October 2024; June 2025; October 2025

Advisory Council Review

Non-AIDS Applications: October 2023; January 2024; October 2024; January 2025; October 2025; January 2026

AIDS Applications: October 2023; January 2024; October 2024; January 2025; October 2025; January 2026

Earliest Start Date

Non-AIDS Applications: February 2024; March 2024; February 2025; March 2025; February 2026; March 2026

AIDS Applications: February 2024; March 2024; February 2025; March 2025; February 2026; March 2026

Expiration Date

September 8, 2025


Revised to read (changes shown in bold italics):

Part 1. Overview Information

Key Dates

Application Due Date(s)

January 11, 2023; June 8, 2023; January 11, 2024; June 11, 2024; January 10, 2025; June 11, 2025; January 12, 2026

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. 

AIDS Application Due Date(s)

May 7, 2023; September 7, 2023; May 7, 2024; September 7, 2024; May 7, 2025; September 7, 2025; May 7, 2026

All applications are due by 5:00 PM local time of applicant organization. All types of AIDS and AIDS-related applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

Scientific Merit Review

Non-AIDS Applications: June 2023; October 2023; June 2024; October 2024; June 2025; October 2025; June 2026

AIDS Applications: June 2023; October 2023; June 2024; October 2024; June 2025; October 2025; June 2026

Advisory Council Review

Non-AIDS Applications: October 2023; January 2024; October 2024; January 2025; October 2025; January 2026; October 2026

AIDS Applications: October 2023; January 2024; October 2024; January 2025; October 2025; January 2026; October 2026

Earliest Start Date

Non-AIDS Applications: February 2024; March 2024; February 2025; March 2025; February 2026; March 2026; February 2027

AIDS Applications: February 2024; March 2024; February 2025; March 2025; February 2026; March 2026; February 2027

Expiration Date

May 8, 2026

All other aspects of the NOFO remain unchanged. 

Inquiries

Please direct all inquiries to:

For the Division of AIDS (DAIDS):

Martin Gutierrez, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-292-4844
Email: [email protected]

For the Division of Allergy Immunology and Transplantation (DAIT):

Halonna Kelly, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3519
Email: [email protected]

For the Division of Microbiology and Infectious Diseases (DMID):

Deirdre Joy, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-627-3284
Email: [email protected]